Cargando…
Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients
The intent of this study was an evaluation of our effort to reduce the incidence of hypercalcemia in critically ill vitamin D-deficient patients with multiple traumatic injuries given cholecalciferol. Vitamin D deficiency was defined as a serum 25-hydroxy vitamin D concentration (25-OH vit D) of <...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032836/ https://www.ncbi.nlm.nih.gov/pubmed/35458212 http://dx.doi.org/10.3390/nu14081650 |
_version_ | 1784692743001341952 |
---|---|
author | Dickerson, Roland N. Turner, Stephen C. Holmes, Whitney L. Van Matre, Edward T. Swanson, Joseph M. Byerly, Saskya Filiberto, Dina M. Fischer, Peter E. |
author_facet | Dickerson, Roland N. Turner, Stephen C. Holmes, Whitney L. Van Matre, Edward T. Swanson, Joseph M. Byerly, Saskya Filiberto, Dina M. Fischer, Peter E. |
author_sort | Dickerson, Roland N. |
collection | PubMed |
description | The intent of this study was an evaluation of our effort to reduce the incidence of hypercalcemia in critically ill vitamin D-deficient patients with multiple traumatic injuries given cholecalciferol. Vitamin D deficiency was defined as a serum 25-hydroxy vitamin D concentration (25-OH vit D) of <20 ng/mL. Adult patients (>17 years of age) were given 10,000 IU of cholecalciferol daily with an intended target 25-OH vit D of >19.9 ng/mL. These patients were compared to a historical control group that underwent therapy with a higher target of >29.9 ng/mL. Patients received cholecalciferol via the feeding tube along with enteral nutrition (EN) until the target 25-OH vit D was achieved, EN discontinued, the nutrition support service signed off the patient, or the patient was discharged from the TICU. Patients were included if two consecutive weekly 25-OH vit D were measured. One hundred and three critically ill trauma patients were retrospectively studied. Fifty were given cholecalciferol therapy with the new lower target 25-OH vit D, and 53 were from a historical cohort aiming for the higher target. Hypercalcemia (serum ionized calcium concentration > 1.32 mmol/L) was reduced from 40% (21 out of 53 patients) to 4% (2 out of 50 patients; p < 0.001). None of the hypercalcemic patients were symptomatic. Readjustment of target 25-OH vit D concentration resulted in a ten-fold decrease in the rate of hypercalcemia and improved the safety of cholecalciferol therapy for critically ill patients with traumatic injuries. |
format | Online Article Text |
id | pubmed-9032836 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90328362022-04-23 Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients Dickerson, Roland N. Turner, Stephen C. Holmes, Whitney L. Van Matre, Edward T. Swanson, Joseph M. Byerly, Saskya Filiberto, Dina M. Fischer, Peter E. Nutrients Article The intent of this study was an evaluation of our effort to reduce the incidence of hypercalcemia in critically ill vitamin D-deficient patients with multiple traumatic injuries given cholecalciferol. Vitamin D deficiency was defined as a serum 25-hydroxy vitamin D concentration (25-OH vit D) of <20 ng/mL. Adult patients (>17 years of age) were given 10,000 IU of cholecalciferol daily with an intended target 25-OH vit D of >19.9 ng/mL. These patients were compared to a historical control group that underwent therapy with a higher target of >29.9 ng/mL. Patients received cholecalciferol via the feeding tube along with enteral nutrition (EN) until the target 25-OH vit D was achieved, EN discontinued, the nutrition support service signed off the patient, or the patient was discharged from the TICU. Patients were included if two consecutive weekly 25-OH vit D were measured. One hundred and three critically ill trauma patients were retrospectively studied. Fifty were given cholecalciferol therapy with the new lower target 25-OH vit D, and 53 were from a historical cohort aiming for the higher target. Hypercalcemia (serum ionized calcium concentration > 1.32 mmol/L) was reduced from 40% (21 out of 53 patients) to 4% (2 out of 50 patients; p < 0.001). None of the hypercalcemic patients were symptomatic. Readjustment of target 25-OH vit D concentration resulted in a ten-fold decrease in the rate of hypercalcemia and improved the safety of cholecalciferol therapy for critically ill patients with traumatic injuries. MDPI 2022-04-15 /pmc/articles/PMC9032836/ /pubmed/35458212 http://dx.doi.org/10.3390/nu14081650 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dickerson, Roland N. Turner, Stephen C. Holmes, Whitney L. Van Matre, Edward T. Swanson, Joseph M. Byerly, Saskya Filiberto, Dina M. Fischer, Peter E. Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients |
title | Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients |
title_full | Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients |
title_fullStr | Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients |
title_full_unstemmed | Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients |
title_short | Reduction in Hypercalcemia Following Readjustment of Target Serum 25-Hydroxy Vitamin D Concentration during Cholecalciferol Therapy in Vitamin D-Deficient Critically Ill Patients |
title_sort | reduction in hypercalcemia following readjustment of target serum 25-hydroxy vitamin d concentration during cholecalciferol therapy in vitamin d-deficient critically ill patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032836/ https://www.ncbi.nlm.nih.gov/pubmed/35458212 http://dx.doi.org/10.3390/nu14081650 |
work_keys_str_mv | AT dickersonrolandn reductioninhypercalcemiafollowingreadjustmentoftargetserum25hydroxyvitamindconcentrationduringcholecalciferoltherapyinvitaminddeficientcriticallyillpatients AT turnerstephenc reductioninhypercalcemiafollowingreadjustmentoftargetserum25hydroxyvitamindconcentrationduringcholecalciferoltherapyinvitaminddeficientcriticallyillpatients AT holmeswhitneyl reductioninhypercalcemiafollowingreadjustmentoftargetserum25hydroxyvitamindconcentrationduringcholecalciferoltherapyinvitaminddeficientcriticallyillpatients AT vanmatreedwardt reductioninhypercalcemiafollowingreadjustmentoftargetserum25hydroxyvitamindconcentrationduringcholecalciferoltherapyinvitaminddeficientcriticallyillpatients AT swansonjosephm reductioninhypercalcemiafollowingreadjustmentoftargetserum25hydroxyvitamindconcentrationduringcholecalciferoltherapyinvitaminddeficientcriticallyillpatients AT byerlysaskya reductioninhypercalcemiafollowingreadjustmentoftargetserum25hydroxyvitamindconcentrationduringcholecalciferoltherapyinvitaminddeficientcriticallyillpatients AT filibertodinam reductioninhypercalcemiafollowingreadjustmentoftargetserum25hydroxyvitamindconcentrationduringcholecalciferoltherapyinvitaminddeficientcriticallyillpatients AT fischerpetere reductioninhypercalcemiafollowingreadjustmentoftargetserum25hydroxyvitamindconcentrationduringcholecalciferoltherapyinvitaminddeficientcriticallyillpatients |